The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
The study, funded by Cancer Research UK, could lead to a blood test which will inform doctors which inflammatory bowel ...
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...
Now, a study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in the next five ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...
Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...
Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...
Researchers have uncovered differences in how patients with South Asian and white ethnicity present with inflammatory bowel ...
Scientists have developed a groundbreaking test that may predict bowel cancer risk with up to 90% accuracy. The research, ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...